Robert M. Califf, MD, has become the second former FDA commissioner to win U.S. Senate confirmation a second time, as senators narrowly approved his returning to the position he held for most of the final year of President Barack Obama’s administration.
Share this article
TUCSON, Ariz., May 19, 2021 /PRNewswire/
Critical Path Institute (C-Path) today announced the appointment of Robert M. Califf, MD, MACC, head of Clinical Policy and Strategy for Google parent company Alphabet s Verily Life Sciences and Google Health divisions, to C-Path s Board of Directors. Califf served as the U.S. Food and Drug Administration (FDA) Commissioner under President Barack Obama s administration from 2016-2017.
Robert M. Califf, MD, MACC
A nationally and internationally recognized expert in cardiovascular medicine, health outcomes research, health care quality and clinical research, Dr. Califf has led many landmark clinical trials and is one of the most frequently cited authors in biomedical science, with more than 1,200 publications in the peer-reviewed literature.
C-Path Welcomes Alphabet Clinical Policy and Strategy Head, Former FDA Commissioner to Board prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
Canterbury Consulting To Host Virtual Annual Investment Forum January 21, 2021
Canterbury s Annual Investment Forum will feature a former commissioner of the FDA, the chief investment strategist at Charles Schwab, and the founder of Ariel Investments as they provide insights on biomedical science and health, international markets, and value investing.
News provided by
Share this article
Share this article
NEWPORT BEACH, Calif., Jan. 18, 2021 /PRNewswire/ Canterbury Consulting, an independent investment advisory firm overseeing more than $23.6 billion in assets as of June 30, 2020, will host its 13th Annual Investment Forum virtually for the first time on January 21, 2021. This year s forum brings together experts in health science and investment management for engaging presentations and discussions on the state the economy, the markets, and the global community.